Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

MHRA recalls more than one hundred batches of drugs

  • Comment

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class two medicines recall of more than one hundred batches of drugs after they were exposed to unsatisfactory conditions during shipment.

The medicines, manufactured by Karib Kemi Pharm Ltd, include batches of amoxicillin, atenolol, ciprofloxacin and ranitidine tablets that were shipped to the UK from India.

According to the agency, temperature problems during shipment could result in the drugs deteriorating over time, and all unexpired stock of the affected batches should be quarantined and returned to the manufacturer.

However, the MHRA stressed that this is only a precautionary measure as there is no evidence to suggest that the medicines are not safe for patient use.

Only specific batches of the drugs contained in the alert need to be returned as batches which have been transported by air are not affected, they added.

A full list of the affected batches of drugs can be found on the MHRA website.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs